HelixNano Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $45M

  • Investors
  • 41

HelixNano General Information

Description

Operator of a native biotechnology company created to enable previously impossible applications across human and non-human biology. The company's platform uses artificial intelligence to leverage synthetic biology to safely and reliably express transgenes in humans for next-generation gene therapies, genome engineering, and beyond, allowing clinicians to treat patients suffering from various diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 5 Channel Center Street
  • Boston, MA 02210
  • United States

HelixNano Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HelixNano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 22-Mar-2022 $45M 000.00 000.00 Completed Pre-Clinical Trials
9. Seed Round 01-Jan-2021 00.000 Completed Pre-Clinical Trials
8. Seed Round 31-Mar-2020 00.00 00.000 Completed Pre-Clinical Trials
7. Grant 08-Feb-2019 00000 00.000 Completed Startup
6. Seed Round 25-Jan-2018 00.00 00.000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 22-Aug-2017 00000 00.000 Completed Startup
4. Seed Round 31-Dec-2016 00.00 00.00 Completed Startup
3. Accelerator/Incubator 01-Nov-2016 00000 Completed Startup
2. Accelerator/Incubator 09-Dec-2014 $100K Completed Startup
1. Accelerator/Incubator 01-Jan-2014 $100K $100K Completed Startup
To view HelixNano’s complete valuation and funding history, request access »

HelixNano Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-9 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-8 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-7 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-6 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-5 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 972,558 $0.000010 $4.18 $4.18 1x $4.18 8.04%
Series A-1 2,870,944 $0.000010 $5.22 $5.22 1x $5.22 23.72%
To view HelixNano’s complete cap table history, request access »

HelixNano Patents

HelixNano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230383287-A1 Acetylated ribonucleic acids and uses thereof Pending 04-May-2022 000000000
US-20230285546-A1 Compositions comprising alpha-factor prepro sequence and uses thereof Pending 05-Jan-2022 0000000000 0
US-20220372477-A1 Modified ribonucleic acids and uses thereof Active 07-May-2021 000000000
US-11639501-B2 Modified ribonucleic acids and uses thereof Active 07-May-2021 0000000000 0
US-20230203488-A1 Modified ribonucleic acids and uses thereof Pending 07-May-2021 C12N15/113 0
To view HelixNano’s complete patent history, request access »

HelixNano Executive Team (5)

Name Title Board Seat Contact Info
Hannu Rajaniemi Ph.D Co-Founder & Chief Executive Officer
Julia Carvalho Chief Operating Officer
Nikolai Eroshenko Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 3 of 5 executive team members. Get the full list »

HelixNano Board Members (2)

Name Representing Role Since
Nicholas Shekerdemian The Venture Collective Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

HelixNano Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HelixNano Investors (41)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beast Ventures Venture Capital Minority 000 0000 000000 0
Bill Silva Ventures Corporate Venture Capital Minority 000 0000 000000 0
Breakthrough Energy Accelerator/Incubator Minority 000 0000 000000 0
Hawktail Venture Capital Minority 000 0000 000000 0
Maksim Kolysh Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 41 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »